key: cord-1017454-zdzpjdxn authors: Chirumbolo, Salvatore title: Nutraceuticals and dietary supplements should not be used to treat COVID-19 as pharmaceuticals date: 2021-09-20 journal: Nutrition DOI: 10.1016/j.nut.2021.111494 sha: b5e3bcad877b6fc2b0bab91c3b5280e106b9914c doc_id: 1017454 cord_uid: zdzpjdxn nan  Plant derived nutraceuticals are widely used to prevent COVID-19  These compounds cannot be used as pharmaceuticals  These compounds are not therapic drugs against COVID-19  Phytochemicals activity is intertwined with flavonoids in food  Poor bioavailability and complex mechanisms are issues of concern Nutraceuticals and dietary supplements should not be used to treat COVID-19 as pharmaceuticals A very recent preprint by Lordan and Rando reviewed the use of dietary supplements and nutraceuticals in COVID-19. Despite the bulk of evidence supporting a role for natural compounds in COVID-19, the authors reported paucity in the clinical evidence of tested compounds such as probiotics, vitamins, poly-unsaturated fatty acids (PUFAs) and zinc in treating COVID-19, assessing that if an improvement is observed, this is only due to the individual's optimal nutritional status, which is able to prime his own immune system and boosting a rapid clearance response against the virus [1] . Despite some evidence showing the beneficial action of ω-3 PUFAs in preventing COVID-19 has been yet reported [2] , the use of nutraceuticals to treat mild or severe forms of COVID-19, raises several controversial issues. Actually, a very recent survey on 372,720 UK participants, of whom 175,652 nutritional supplement users and 197,068 not, reported that a very modest association might exist between lower risk in being SARS.CoV2 positive and diets enriched with probiotics, multivitamin, vitamin D and ω3 fatty acids, despite the study resulted positive only for female subjects [2] . Anyway, clinical trials are crucial to assess any purported effect. Phytochemicals sold as dietary supplements should be used only to potentiate and improve the nutritional status of a subject, particularly upon micronutrients deficiency, usually in order to prevent further damage due to the onset of an inflammation or an exacerbated immune and stress response. Interestingly, Lordan and Rando's contribution did not address polyphenolic compounds from plants, despite their widespread use as nutraceuticals [1] . A huge amount of reports, about 250 articles in "flavonoids AND COVID-19" on Pubmed/Medline, deals with the use of natural phytochemicals in addressing the COVID-19 pandemic, most of which are purported to possess specific ability in targeting virus entry, budding, replication and life cycle of SARS-CoV2, with high specificity [3] . This would erroneously suggest the naïve thesis that nature-derived phytochemicals may act in a pharmacological way. First, it is widely known that the actual bioavailability of any polyphenolic compound from either raw food or nutritional supplements, is hard to be assessed, as flavonoid pharmacokinetics is greatly affected by the gut microbiome composition, therefore is quite impossible establishing a reliable dosage and a reliable dose-effect on the patient. Second, the panoply of actions towards the oxidative stress signaling is highly complex and depending on a great number of factors related with the disease progress and the host's response. Third, the activity of a polyphenolic compound, such as a flavonoid, may be completely reversed or attenuated by other phytochemicals coming from diet, usually in a way very hard to be fully elucidated. The equivocal belief that flavonoids in nutritional supplementation may act in a pharmacological way, is related to the numerous in vitro reports showing the ability of aglycone flavonoids to suppress, enhance and modulate many cell molecular pathways, usually targeting defined signaling systems or receptors or other macromolecular complexes in a fashion very close to pharmaceuticals. Despite this perspective may appear convincing, actually flavonoids are highly pleiotropic and their activity can be perfectly restricted to the simple survival system of the oxidative stress response. Fundamentally, any phytochemical from plants is a toxic compound, which, in a narrow range of dosage, can trigger an oxidative stress response able to activate cell survival, via the production of reactive oxygen species (ROS) as signaling molecules. The correct dose to elicit a benefit is usually established by a certain empiricism, as flavonoids pharmacokinetic is very complex, and this may put the patient towards adverse effects due to the compound sub-clinical toxicity. In this context, To date, no sound association between COVID-19 prevalence and flavonoid-rich food intake has been reported. Furthermore, while literature is endowed with a very large number of papers dealing with flavonoids beneficial effects (e.g. hesperidin), studies on toxicity are usually restricted to one or very few reports [7] . The paroxysmal attitude to rapidly plan a highly successful therapy against COVID-19, is crowding the scientific community of proposals from natural and complementary medicine, sometimes with even potential competing interests. Any proposal is settled to enhance the weapons against pandemic but the misleading consideration that a food-derived phytochemical may be considered a pharmaceutical, raises controversial issues and may hamper the ethical movement to correctly address COVID-19. Methodology: Salvatore Chirumbolo Project administration: NA Resources: Salvatore Chirumbolo Software: Salvatore Chirumbolo Supervision: Salvatore Chirumbolo Validation: Salvatore Chirumbolo Visualization: Salvatore Chirumbolo Roles/Writing -original draft: Salvatore Chirumbolo Writing -review & editing: Salvatore Chirumbolo References COVID-19 Review Consortium, Greene CS. Dietary Supplements and Nutraceuticals Under Investigation for COVID-19 Prevention and Treatment Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app Potential use of polyphenols in the battle against COVID-19 Characterization of orange juice (Citrus sinensis) by flavanone glycosides Quantitative analysis of narirutin, naringin, hesperidin, and neohesperidin in Citrus Hesperetin's health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in Sprague Dawley rats Authorship statements: the paper was completely conceived and written by Salvatore Chirumbolo The author states he has no conflict of interest